Maurizio Vertemati

Prof. Dr. Maurizio Vertemati

University of Milan, Milan, Lombardy, Italy
orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2001 in Journal of Clinical Gastroenterology
Verified
Journal Article
Closed access
Paolo AseniPaolo Aseni
Paolo Aseni
CSCosimo Vincenzo Sansalone
Cosimo Vincenzo Sansalone
CSCinzia Sammartino
Cinzia Sammartino
FBFabrizio Di Benedetto
Fabrizio Di Benedetto
GCGianpaolo Carrafiello
Gianpaolo Carrafiello
DFDomenico Forti
Domenico Forti
We present the case of a 25-year-old woman who developed a large central liver adenoma after 8 years of continuous oral contraceptive use. The first diagnosis was made by ultrasonography, after a rise in plasmatic gamma-glutamyl-transpeptidase and alkaline phosphatase levels was noted. Withdrawal of the oral contraceptive was followed by shrinkage of the adenoma, with complete disappearance 9 months after the diagnosis. Hepatic adenoma (HA) still presents problems in terms of differential diagnosis and clinical management. There are reports of complete or partial regression of an HA after discontinuation of oral contraceptives, but they are poorly documented. To our knowledge, a patient with such rapid disappearance of a large HA has never been reported.

1 March 2000 in The American Journal of Surgery
Verified
Journal Article
Closed access
CSCosimo V Sansalone
Cosimo V Sansalone
Paolo AseniPaolo Aseni
Paolo Aseni
EMEnrico Minetti
Enrico Minetti
FBFabrizio Di Benedetto
Fabrizio Di Benedetto
OROrnella Rossetti
Ornella Rossetti
DFDomenico Forti
Domenico Forti

1 May 2021 in The American Journal of Surgery
Verified
Journal Article
Closed access
Paolo AseniPaolo Aseni
Paolo Aseni
FRFrancesco Rizzetto
Francesco Rizzetto
AGAntonino Massimiliano Grande
Antonino Massimiliano Grande
RBRoberto Bini
Roberto Bini
FSFabrizio Sammartano
Fabrizio Sammartano
MVMaurizio Vertemati
Maurizio Vertemati

1 October 2020 in The American Journal of Surgery
Verified
Journal Article
Closed access
FRFrancesco Rizzetto
Francesco Rizzetto
ABAlessandro Bernareggi
Alessandro Bernareggi
SRSofia Rantas
Sofia Rantas
AVAngelo Vanzulli
Angelo Vanzulli
MVMaurizio Vertemati
Maurizio Vertemati

1 September 2001 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
Paolo AseniPaolo Aseni
Paolo Aseni
MVMaurizio Vertemati
Maurizio Vertemati
EMErnesto Minola
Ernesto Minola
KAKatia Arcieri
Katia Arcieri
EBEdgardo Bonacina
Edgardo Bonacina
DFDomenico Forti
Domenico Forti
The clinical course and outcome of 5 adult patients who underwent orthotopic liver transplantation (OLT) and developed Kaposi’s sarcoma (KS) is reported. From October 1986 to July 2000, a total of 459 patients underwent 499 OLTs at our hospital. The immunosuppressive regimen consisted of cyclosporine, azathioprine, prednisone, and antithymocyte globulin. Tacrolimus was administered only in selected patients. Five patients developed KS, and the pathological diagnosis was established months 9 to 23 after OLT. Four of 5 patients died of KS, surviving 0 to 6 months after pathological diagnosis. The fifth patient, with KS confined to the skin, is disease free 6 months after diagnosis. All patients were treated with reduction of immunosuppressive therapy and/or chemotherapy. Retrospective molecular investigation by polymerase chain reaction for human herpesvirus type 8 DNA detected specific viral sequences in histological specimens of tissues involved by KS. In our experience with adult liver transplant recipients, we registered a slightly lower prevalence of KS compared with other reported data, but observed a high rate of graft involvement and mortality.

11 January 2019 in Surgical Innovation
Verified
Journal Article
Closed access
MVMaurizio Vertemati
Maurizio Vertemati
SCSimone Cassin
Simone Cassin
FRFrancesco Rizzetto
Francesco Rizzetto
AVAngelo Vanzulli
Angelo Vanzulli
MEMarco Elli
Marco Elli
MGMaurizio Gallieni
Maurizio Gallieni
Introduction . With the availability of low-cost head-mounted displays (HMDs), virtual reality environments (VREs) are increasingly being used in medicine for teaching and clinical purposes. Our aim was to develop an interactive, user-friendly VRE for tridimensional visualization of patient-specific organs, establishing a workflow to transfer 3-dimensional (3D) models from imaging datasets to our immersive VRE. Materials and Methods . This original VRE model was built using open-source software and a mobile HMD, Samsung Gear VR. For its validation, we enrolled 33 volunteers: morphologists (n = 11), trainee surgeons (n = 15), and expert surgeons (n = 7). They tried our VRE and then filled in an original 5-point Likert-type scale 6-item questionnaire, considering the following parameters: ease of use, anatomy comprehension compared with 2D radiological imaging, explanation of anatomical variations, explanation of surgical procedures, preoperative planning, and experience of gastrointestinal/neurological disorders. Results in the 3 groups were statistically compared using analysis of variance. Results . Using cross-sectional medical imaging, the developed VRE allowed to visualize a 3D patient-specific abdominal scene in 1 hour. Overall, the 6 items were evaluated positively by all groups; only anatomy comprehension was statistically significant different among the 3 groups. Conclusions . Our approach, based on open-source software and mobile hardware, proved to be a valid and well-appreciated system to visualize 3D patient-specific models, paving the way for a potential new tool for teaching and preoperative planning.